
Repligen Acquires Bioprocessing Analytics Portfolio from 908 Devices
Repligen Acquires Bioprocessing Analytics Portfolio from 908 Devices Repligen Acquires Bioprocessing Analytics Portfolio from 908 Devices Repligen Corporation, a leader in bioprocessing technology, has announced the acquisition of 908 Devices Inc.’s desktop portfolio for process analytical technology (PAT) applications. This…











